상세 보기
The clinical outcomes of rituximab biosimilar CT-P10 (Truxima(R)) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience
- Lee, Kyoungmin;
- Ha, Joo Young;
- Jung, Ah Ra;
- Lee, Yoon Sei;
- Lee, Sang-wook;
- 외 7명
Citations
WEB OF SCIENCE
16Citations
SCOPUS
19초록
This research was funded by the National Research Foundation of Korea, grant numbers MSIP; 2019R1H1A1080141 awarded to Y.S.L. Medical editing support (including copyediting) was provided by Beatrice Tyrrell, DPhil at Aspire Scientific (Bollington, UK) and funded by Celltrion Healthcare Co., Ltd (Incheon, Republic of Korea).
키워드
Diffuse large B-cell lymphoma; biosimilar; rituximab; CT-P10; Truxima(R); real-world evidence; R-CHOP; PLUS CYCLOPHOSPHAMIDE; FOLLICULAR LYMPHOMA; PARALLEL-GROUP; DOUBLE-BLIND; EFFICACY; PHARMACOKINETICS; CLASSIFICATION; CHEMOTHERAPY; VINCRISTINE
- 제목
- The clinical outcomes of rituximab biosimilar CT-P10 (Truxima(R)) with CHOP as first-line treatment for patients with diffuse large B-cell lymphoma: real-world experience
- 저자
- Lee, Kyoungmin; Ha, Joo Young; Jung, Ah Ra; Lee, Yoon Sei; Lee, Sang-wook; Ryu, Jin-Sook; Chae, Eun Jin; Kim, Kyung Won; Huh, Jooryung; Park, Chan-Sik; Yoon, Dok Hyun; Suh, Cheolwon
- 발행일
- 2020-06
- 유형
- Article; Early Access
- 권
- 61
- 호
- 7
- 페이지
- 1575 ~ 1583
- 언어
- ENG
- 출판사
- Taylor & Francis
- 발행국가
- 영국
- 분량
- 9 페이지
- ISSN
- E 1029-2403
P 1042-8194